1887

Chapter 30 : Mycobacterium: General Characteristics, Laboratory Detection, and Staining Procedures*

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Mycobacterium: General Characteristics, Laboratory Detection, and Staining Procedures*, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch30-1.gif /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch30-2.gif

Abstract:

Many species within the genus are prominent pathogens, above all members of the complex, , and . In addition, there are, at present, more than 150 species of environmental mycobacteria (nontuberculous mycobacteria [NTM]) which exert various degrees of pathogenicity and virulence in humans. This chapter describes clinical, taxonomic, genetic, and epidemiologic aspects of these organisms and includes the characteristics and clinical significance of novel species. Emphasis is put on laboratory diagnosis of mycobacteria, which includes staining procedures, detection by microscopic procedures, protocols for collection and pretreatment of clinical specimens, culture, and quality assurance, as well as safety and transport issues. Furthermore, evaluation, interpretation, and reporting of results are addressed. The practical value and the current state of knowledge of the immunodiagnostic tests for tuberculosis (interferon gamma release assays [IGRAs]) are also discussed.

Citation: Pfyffer G. 2015. Mycobacterium: General Characteristics, Laboratory Detection, and Staining Procedures*, p 536-569. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch30
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

(Top left) on Middlebrook 7H10 agar. Note the dry and rough colonies, which sometimes have a nodular or wrinkled surface. doi:1128/9781555817381.ch30.f1

Citation: Pfyffer G. 2015. Mycobacterium: General Characteristics, Laboratory Detection, and Staining Procedures*, p 536-569. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

(Top right) BCG on Middlebrook 7H10 agar. Colonies may be flat as well as round with irregular edges. doi:1128/9781555817381.ch30.f2

Citation: Pfyffer G. 2015. Mycobacterium: General Characteristics, Laboratory Detection, and Staining Procedures*, p 536-569. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

(Bottom left) Acid-fast staining (Ziehl-Neelsen) of . Note the characteristic curved (“croissant-like”) microscopic morphology. doi:1128/9781555817381.ch30.f3

Citation: Pfyffer G. 2015. Mycobacterium: General Characteristics, Laboratory Detection, and Staining Procedures*, p 536-569. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

(Bottom right) on Middlebrook 7H10 agar. Note the heterogeneous colony morphology consisting of some flat and smooth but predominantly domed and glossy colonies (photograph kindly provided by D. van Soolingen). doi:1128/9781555817381.ch30.f4

Citation: Pfyffer G. 2015. Mycobacterium: General Characteristics, Laboratory Detection, and Staining Procedures*, p 536-569. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817381.mcm11.ch30
1. World Health Organization. 2012. Global tuberculosis report. WHO Report 2012. World Health Organization, Geneva, Switzerland. http://www.who/int/tb/publications/global_report/en/.
2. American Thoracic Society. 2007. Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367416.
2. Falkinham JO. 1996. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9:178215.
4. Falkinham JO. 2013. Ecology of nontuberculous mycobacteria—where do human infections come from? Semin Respir Crit Care Med 34:95102.
5. Tortoli E. 2003. Impact of genotypic studies in mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 16:319354.
6. Primm TP,, Lucero CA,, Falkinham JO,III. 2004. Health impacts of environmental mycobacteria. Clin Microbiol Rev 17:98106.
7. Wayne LG,, Kubica GP,. 1986. Mycobacteria, p 1435–1457. In Sneath PHA (ed), Bergey’s Manual of Systemic Bacteriology, vol 2. William’s & Wilkins, Baltimore, MD.
8. Conville PS,, Witebsky FG,. 2005. Nocardia and other aerobic actinomycetes, p 1137–1180. In Boriello SP,, Murray PR,, Funke G (ed), Topley & Wilson’s Microbiology and Microbial Infections, Bacteriology, 10th ed, vol 2. Hodder Arnold, London, United Kingdom.
9. Butler RW,, Floyd MM,, Brown JM,, Toney SR,, Daneshvar MI,, Cooksey RC,, Carr J,, Steigerwalt AG,, Charles N. 2005. Novel mycolic acid-containing bacteria in the family Segniliparaceae fam. nov., including the genus Segniliparus gen. nov., with descriptions of Segniliparus rotundus sp. nov. and Segniliparus rugosus sp. nov. Int J Syst Evol Microbiol 55:16151624.
10. Ghosh J,, Larsson P,, Singh B,, Pettersson BM,, Islam NM,, Sarkar SN,, Dasgupta S,, Kirsebom LA. 2009. Sporulation in mycobacteria. Proc Natl Acad Sci U S A 106:1078110786.
11. Kremer L,, Besra GS,. 2005. A waxy tale, by Mycobacterium tuberculosis, p 287–305. In Cole ST,, Eisenach KD,, McMurray DN,, Jacobs WR,Jr (ed), Tuberculosis and the Tubercle Bacillus. ASM Press, Washington, DC.
12. Wheeler PR,, Blanchard JS,. 2005. General metabolism and biochemical pathways of tubercle bacilli, p 309–339. In Cole ST,, Eisenach KD,, McMurray DN,, Jacobs WR,Jr (ed), Tuberculosis and the Tubercle Bacillus. ASM Press, Washington, DC.
13. Mitscherlich E,, Marth EH. 1984. Microbial Survival in the Environment—Bacteria and Rickettsiae Important in Human and Animal Health, p 232–266. Springer-Verlag, Berlin, Germany.
14. World Health Organization. 2012. Tuberculosis Laboratory Biosafety Manual. WHO, Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/77949/1/9789241504638_eng.pdf.
15. Chosewood LC,, Wilson DE (ed). 2007. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. Centers for Disease Control and Prevention, Washington, DC. http://www.cdc.gov/od/ohs.
16. Fleming DO,, Hunt DL. 2006. Biological Safety: Principles and Practices, 4th ed. ASM Press, Washington, DC.
17. Allen S,, Batungwanayo J,, Kerlikowske K,, Lifson AR,, Wolf W,, Granich R,, Taelman H,, van de Perre P,, Serufilira A,, Bogaerts J. 1992. Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am Respir Dis 146:14391444.
18. Brown-Elliott BA,, Wallace RJ,, Tichindelean C,, Sarria JC,, McNulty S,, Vasireddy R,, Bridge L,, Mayall CG,, Turenne C,, Loeffelholz M. 2011. Five-year outbreak of community- and hospital-acquired Mycobacterium porcinum infections related to public water supplies. J Clin Microbiol 49:42314238.
19. Wallace R,, Iakhiaeva E,, Williams MD,, Brown-Elliott BA,, Vasireddy R,, Lande L,, Peterson DD,, Sawicki J,, Kwait R,, Tichenor WS,, Turenne C,, Falkinham JO. 2013. Absence of Mycobacterium intracellulare and the presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease. J Clin Microbiol 51:17471752.
20. Marshall HM,, Carter R,, Torbey MJ,, Minion S,, Tolson C,, Sidjabat HE,, Huygens F,, Hargreaves M,, Thomson RM. 2011. Mycobacterium lentiflavum in drinking water supplies, Australia. Emerg Infect Dis 17:395402.
21. Hernandez-Garduno E,, Elwood K. 2012. Nontuberculous mycobacteria in tap water. Emerg Infect Dis 18:353.
22. Brosch R,, Gordon SV,, Marmiesse M,, Brodin P,, Buchrieser C,, Eiglmeier K,, Garnier T,, Gutierrez C,, Hewinson G,, Kremer K,, Parsons LM,, Pym AS,, Samper S,, van Soolingen D,, Cole ST. 2002. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 99:36843689.
23. Gagneux S,, DeRiemer K,, Van T,, Kato-Maeda M,, de Jong BC,, Narayanan S,, Nicol M,, Niemann S,, Kremer K,, Gutierrez MC,, Hilty M,, Hopewell PC,, Small PM. 2006. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 103:28692873.
24. Gutierrez MC,, Brisse S,, Brosch R,, Fabre M,, Omaïs B,, Marmiesse M,, Supply P,, Vincent V. 2005. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog 1(1):e5.
25. Gandhi NR,, Shah NS,, Andrews JR,, Vella V,, Moll AP,, Scott M,, Weissman D,, Marra C,, Lalloo UG,, Friedland GH. 2010. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med 181:8086.
26. Hopewell PC,, Jasmer RM,. 2005. Overview of clinical tuberculosis, p 15–31. In Cole ST,, Eisenach KD,, McMurray DN,, Jacobs WR,Jr (ed), Tuberculosis and the Tubercle Bacillus. ASM Press, Washington, DC.
27. Cole ST,, Brosch R,, Parkhill J,, Garnier T,, Churcher C,, Harris D,, Gordon SV,, Eiglmeier K,, Gas S,III,, Barry CE,, Tekaia F,, Badcock K,, Basham D,, Brown D,, Chillingworth T,, Connor R,, Davies R,, Devlin K,, Feltwell T,, Gentles S,, Hamlin N,, Holroyd S,, Hornsby T,, Jagels K,, Krogh A,, Maclean J,, Moule S,, Murphy L,, Oliver K,, Osborne J,, Quail MA,, Rajandream MA,, Rogers J,, Rutter S,, Seeger K,, Skelton J,, Squares R,, Squares S,, Sulston JE,, Taylor K,, Whitehead S,, Barrell BG. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537544.
28. Karboul A,, Gey van Pittius NC,, Namouchi A,, Vincent V,, Sola C,, Rastogi N,, Suffys P,, Fabre M,, Cataldi A,, Huard RC,, Kurepina N,, Kreiswirth B,, Ho JL,, Gutierrez MC,, Mardassi H. 2006. Insights into the evolutionary history of tubercle bacilli as disclosed by genetic rearrangements within a PE_PGRS duplicated gene pair. BMC Evol Biol 6:107125.
29. Blouin Y,, Hauck Y,, Soler C,, Fabre M,, Vong R,, Dehan C,, Cazajous G,, Massoure P-L,, Kraemer P,, Jenkins A,, Garnotel E,, Pourcel C,, Vergnaud G. 2012. Significance of the identification in the Horn of Africa of an exceptionally deep branching Mycobacterium tuberculosis clade. PLoS One 7:e52841. 10.1371/journal.pone.0052841
30. Majoor CJ,, Magis-Escurra C,, van Ingen J,, Boeree MJ,, van Soolingen D. 2011. Epidemiology of Mycobacterium bovis disease in humans, the Netherlands, 1993–2007. Emerg Infect Dis 17:457463.
31. Garnier T,, Eiglmeier K,, Camus J-C,, Medina N,, Mansoor H,, Pryor M,, Duthoy S,, Grondlin S,, Lacroix C,, Monsempe C,, Simon S,, Harris B,, Atkin R,, Doggett J,, Mayes R,, Keating L,, Wheeler PR,, Parkhill J,, Barrell BG,, Cole ST,, Gordon SV,, Hewinson RG. 2003. The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci U S A 100:78777882.
32. Behr MA,, Small PM. 1999. A historical and molecular phylogeny of BCG strains. Vaccine 17:915922.
33. Supply P,, Mazars E,, Lesjean S,, Vincent V,, Gicquel B,, Locht C. 2000. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol 36:762771.
34. Siatelis A,, Houhoula D,, Papaparaskevas J,, Delakas D,, Tsakiris A. 2011. Detection of Bacillus Galmette-Guérin (Mycobacterium bovis BCG) DNA in urine and blood specimens after intravesical immunotherapy for bladder carcinoma. J Clin Microbiol 49:12061208.
35. Kanamori H,, Isogami K,, Hatakeyama T,, Saito H,, Shimada K,, Uchiyama B,, Aso N,, Kaku M. 2012. Chest wall abscess due to Mycobacterium bovis BCG after intravesical BCG therapy. J Clin Microbiol 50:533535.
36. Brosch R,, Gordon SV,, Garnier T,, Eiglmeier K,, Frigui W,, Valenti P,, Dos Santos S,, Duthoy S,, Lacroix S,, Garcia-Pelayo C,, Inwald JK,, Golby P,, Garcia JN,, Hewinson RG,, Behr MA,, Quai MA,, Churcher C,, Barrell BG,, Parkhill J,, Cole ST. 2007. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci U S A 104:55965601.
37. Joshi D,, Harris NB,, Waters R,, Thacker T,, Mathema B,, Kreiswirth B,, Sreevatsan S. 2012. Single nucleotide polymorphisms in the Mycobacterium bovis genome resolve phylogenetic relationships. J Clin Microbiol 50:38533861.
38. de Jong BC,, Antonio M,, Gagneux S. 2010. Mycobacterium africanum—review of an important cause of human tuberculosis in West Africa. PLoS Negl Trop Dis 4:e744.
39. Desmond E,, Ahmed AT,, Probert WS,, Ely J,, Jang Y,, Sanders SA,, Lin S-Y,, Flood J. 2004. Mycobacterium africanum cases, California. Emerg Infect Dis 10:921923.
40. Isea-Pena MC,, Brezmes-Valdivieso MF,, Gonzalez-Velasco MC,, Lezcano-Carrera MA,, Lopez-Urrutia-Lorente L,, Martin-Casabona N,, Monforte-Cirac ML,, Palacios JJ,, Penedo-Pallares A,, Ramirez-Rosales A,, Sanchez-Silos R,, Tortola-Fernandez T,, Vinuelas-Bayron J,, Vitoria-Agreda A. 2012. Mycobacterium africanum, an emerging disease in high-income countries? Int J Tuberc Lung Dis 16:14001404.
41. Bentley SD,, Comas I,, Bryant JM,, Walker D,, Smith NH,, Harris SR,, Thurston S,, Gagneux S,, Wood J,, Antonio M,, Quall MA,, Gehre F,, Adegbola RA,, Parkhill J,, de Jong BC. 2012. The genome of Mycobacterium africanum West African 2 reveals a lineage-specific locus and genome erosion common to the M. tuberculosis complex. PLoS Negl Trop Dis 6:e1552. doi:10.1371/journal.pntd.0001552.
42. Aranaz A,, Liebana E,, Gomez-Mampaso E,, Galan JC,, Cousins D,, Blazquez J,, Baquero F,, Mateos A,, Suarez G,, Dominguez L. 1999. Mycobacterium tuberculosis subsp. caprae subsp. nov.: a taxonomic study of the Mycobacterium tuberculosis complex isolated from goats in Spain. Int J Syst Bacteriol 49:12631273.
43. Kubica T,, Rüsch-Gerdes S,, Niemann S. 2003. Mycobacterium bovis subsp. caprae caused one-third of human M. bovis-associated tuberculosis cases reported in Germany between 1999 and 2001. J Clin Microbiol 41:30703077.
44. Rodriguez S,, Bezos J,, Romero B,, de Juan L,, Alvarez J,, Castellanos E,, Moya N,, Lozano F,, Tariq Javed M,, Saez-Llorente JL,, Liebana E,, Mateos A,, Dominguez L,, Aranaz A. 2011. Mycobacterium caprae infection in livestock and wildlife, Spain. Emerg Infect Dis 17:532535.
45. Prodinger WM,, Brandstätter A,, Naumann L,, Pacciarini M,, Kubica T,, Boschiroli LM,, Aranaz A,, Nagy G,, Cvetnic Z,, Ocepek M,, Skrypnyk A,, Erler W,, Niemann S,, Pavlik I,, Moser I. 2005. Characterization of Mycobacterium caprae isolates from Europe by mycobacterial interspersed repetitive unit genotyping. J Clin Microbiol 43:49844992.
46. Domogalla J,, Prodinger WM,, Blum H,, Krebs S,, Gellert S,, Müller M,, Neuendorf E,, Sedlmaier F,, Büttner M. 2013. Region of difference four (RD4) in alpine Mycobacterium caprae isolates indicates three variants. J Clin Microbiol 51:13811388.
47. Oevermann A,, Pfyffer GE,, Zanolari P,, Meylan M,, Robert N. 2004. Generalized tuberculosis in Llamas (Lama glama) due to Mycobacterium microti. J Clin Microbiol 42:18181821.
48. Alvarez J,, Bezos J,, de Juan L,, Vordermeier M,, Rodriguez S,, Fernandez-de-Mera IG,, Mateos A,, Dominguez L. 2011. Diagnosis of tuberculosis in camelids: old problems, current solutions and future challenges. Transbound Emerg Dis 59:110.
49. Rüfenacht S,, Bögli-Stuber K,, Bodmer T,, Jaunin VF,, Jmaa DC,, Gunn-Moore DA. 2011. Mycobacterium microti infection in the cat: a case report, literature review and recent clinical experience. J Feline Med Surg 13:195204.
50. Bennett AD,, Lalor S,, Schwarz T,, Gunn-Moore DA. 2011. Radiographic findings in cats with mycobacterial infections. J Feline Med Surg 13:718724.
51. Palgrave CJ,, Benato L,, Eatwell K,, Laurenson IF,, Smith NH. 2012. Mycobacterium microti infection in two meerkats (Suricata suricatta). J Comp Pathol 146:278282.
52. van Soolingen D,, van der Zanden AGM,, de Haas PEW,, Noordhoek GT,, Kiers A,, Foudraine NA,, Portaels F,, Kolk AHJ,, Kremer K,, van Embden JDA. 1998. Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers. J Clin Microbiol 36:18401845.
53. de Jong E,, Rentenaar RJ,, van Pelt R,, de Lange W,, Schreurs W,, van Soolingen D,, Sturm PDJ. 2009. Two cases of Mycobacterium microti-induced culture-negative tuberculosis. J Clin Microbiol 47:30383040.
54. Panteix G,, Gutierrez MC,, Boschiroli ML,, Rouviere M,, Plaidy A,, Pressac D,, Porcheret H,, Chyderiotis G,, Ponsada M,, van Oortegem K,, Salloum S,, Cabuzel S,, Banuls AL,, van de Perre P,, Godreuil S. 2010. Pulmonary tuberculosis due to Mycobacterium microti: a study of six recent cases in France. J Med Microbiol 59:984989.
55. Frota CC,, Hunt DM,, Buxton RS,, Rickman L,, Hinds J,, Kremer K,, van Soolingen D,, Colston MJ. 2004. Genome structure in the vole bacillus, Mycobacterium microti, a member of the Mycobacterium tuberculosis complex with a low virulence for humans. Microbiology 15:15191527.
56. van Soolingen D,, Hoogenboezem T,, de Haas PEW,, Hermans PWM,, Koedam MA,, Teppema KS,, Brennan PJ,, Besra GS,, Portaels F,, Top J,, Schouls LM,, van Embden JDA. 1997. A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canettii: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol 47:12361245.
57. Pfyffer GE,, Auckenthaler R,, van Embden JDA,, van Soolingen D. 1998. Mycobacterium canettii, the smooth variant of M. tuberculosis, isolated from a Swiss patient exposed in Africa. Emerg Infect Dis 4:631634.
58. Fabre M,, Koeck J-L,, Le Flèche P,, Simon F,, Hervé V,, Vergnaud G,, Pourcel C. 2004. High genetic diversity revealed by variable-number tandem repeat genotyping and analysis of hsp65 gene polymorphism in a large collection of “Mycobacterium canettii” strains indicates that the M. tuberculosis complex is a recently emerged clone of “M. canettii.” J Clin Microbiol 42:32483255.
59. Miltgen J,, Morillon M,, Koeck JL,, Varnerot A,, Briant JF,, Nguyen G,, Verrot D,, Bonnet D,, Vincent V. 2002. Two cases of pulmonary tuberculosis caused by Mycobacterium tuberculosis subsp. canettii. Emerg Infect Dis 8:13501352.
60. Somoskövi A,, Dormandy J,, Mayrer AR,, Carter M,, Hooper N,, Salfinger M. 2009. Mycobacterium canettii” isolated from a human immunodeficiency virus-positive patient: first case recognized in the United States. J Clin Microbiol 47:255257.
61. Marmiesse M,, Brodin P,, Buchrieser C,, Gutierrez C,, Simoes N,, Vincent V,, Glaser P,, Cole ST,, Brosch R. 2004. Macro-array and bioinformatics analyses reveal mycobacetrial ‘core’ genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex. Microbiology 150:483496.
62. Supply P,, Marceau M,, Mangenot S,, Roche D,, Rouanet C,, Khanna V,, Majlessi L,, Criscuolo A,, Tap J,, Pawlik A,, Fiette L,, Orgeur M,, Fabre M,, Parmentier C,, Frigui W,, Simeone R,, Boritsch EC,, Debrie A-S,, Willery E,, Walker D,, Quail MA,, Ma L,, Bouchier C,, Salvignol G,, Sayes F,, Cascioferro A,, Seemann T,, Barbe V,, Locht C,, Gutierrez M-C,, Leclerc C,, Bentley SD,, Stinear TP,, Brisse S,, Médigue C,, Parkhill J,, Cruveiller S,, Brosch R. 2013. Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nat Genet 2:172181.
63. Cousins DV,, Bastida R,, Cataldi A,, Quse V,, Redrobe S,, Dow S,, Duignan P,, Murray A,, Dupont C,, Ahmed N,, Collins DM,, Butler WR,, Dawson D,, Rodriguez P,, Loureiro J,, Romano MI,, Alito A,, Zumarraga M,, Bernardelli A. 2003. Tuberculosis in seals caused by a novel member of the Mycobacterium tuberculosis complex: Mycobacterium pinnipedii sp. nov?. Int J Syst Evol Microbiol 53:13051314.
64. Jurczynski K,, Lyashchenko KP,, Gomis D,, Moser I,, Greenwald R,, Moisson P. 2011. Pinniped tuberculosis in Malayan tapirs (Tapirus indicus) and its transmission to other terrestrian mammals. J Zoo Wildl Med 42:222227.
65. Kiers A,, Klarenbeek A,, Mendelts B,, van Soolingen D,, Koëter G. 2008. Transmission of Mycobacterium pinnipedii to humans in a zoo with marine mammals. Int J Tuberc Lung Dis 12:14691473.
66. Alexander KA,, Laver PN,, Michel AL,, Williams M,, van Helden PD,, Warren RM,, Gey van Pittius NC. 2010. Novel Mycobacterium tuberculosis complex pathogen, M. mungi. Emerg Infect Dis 16:12961299.
67. Gey van Pittius NC,, van Helden PD,, Warren RM. 2012. Characterization of Mycobacterium orygis. Emerg Infect Dis 18:17081709.
68. Gey van Pittius NC,, Perrett KD,, Michel AL,, Keet DF,, Hlokwe T,, Streicher EM,, Warren RM,, van Helden PD. 2012. Infection of African buffalo (Syncerus caffer) by oryx bacillus, a rare member of the antelope clade of Mycobacterium tuberculosis. J Wildl Dis 48:849857.
69. van Ingen J,, Rahim Z,, Mulder A,, Boeree MJ,, Simeone R,, Brosch R,, van Soolingen D. 2012. Characterization of Mycobacterium orygis as M. tuberculosis complex subspecies. Emerg Infect Dis 18:653656.
70. World Health Organization. 2012. Global leprosy situation, 2012. Wkly Epidemiol Rep 87:317328. http://www.who.int./wer.
71. Loughry WJ,, Trumman RW,, McDonough CM,, Tilak MK,, Garnier S,, Delsuc F. 2009. Is leprosy spreading among nine-banded armadillos in the southeastern United States? J Wildl Dis 45:144152.
72. Fite GL,, Cambre FJ,, Hunt MH. 1947. Procedures for demonstrating lepra bacilli in paraffin sections. Arch Pathol 43:624625.
73. Sakamuri RM,, Kimura M,, Li W,, Kim HC,, Lee H,, Madanahally K,, Blackiv WC,IV,, Balagon M,, Gelber R,, Cho SN,, Brennan PJ,, Vissa V. 2009. Population-based molecular epidemiology of leprosy in Cebu, Philippines. J Clin Microbiol 47:28442854.
74. Cambau E,, Chauffour-Nevejans A,, Tejmar-Kolar L,, Matsuoka M,, Jarlier V. 2012. Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test. PLoS Negl Trop Dis 6:e1739. 10.1371/journal.pntd.0001739.
75. Cole ST,, Eiglmeier K,, Parkhill J,, James KD,, Thomson NR,, Wheeler PR,, Honoré N,, Garnier T,, Churcher C,, Harris D,, Mungall,, Basham D,, Brown D,, Chillingworth T,, Connor R,, Davies RM,, Devlin K,, Duthoy S,, Feltwell T,, Fraser A,, Hamlin N,, Holroyd S,, Hornsby T,, Jagels K,, Lacroix C,, Maclean J,, Moule S,, Murphy L,, Oliver K,, Quail MA,, Rajandream MA,, Rutherford KM,, Rutter S,, Seeger K,, Simon S,, Simmonds M,, Skelton J,, Squares S,, Stevens K,, Taylor K,, Whitehead S,, Woodward JR,, Barrell BG. 2001. Massive gene decay in the leprosy bacillus. Nature 409:10071011.
76. Rojas-Espinosa O,, Lovik M. 2001. Mycobacterium leprae and Mycobacterium lepraemurium infections in domestic and wild animals. Rev Sci Tech 20:219251.
77. Vera-Cabrera L,, Escalante-Fuentes WG,, Gomez-Flores M,, Ocampo-Candiani J,, Busso P,, Singh P,, Cole ST. 2011. Base of diffuse lepromatous leprosy associated with “Mycobacterium lepromatosis.” J Clin Microbiol 49:43664368.
78. Jessamine PG,, Desjardins M,, Gillis T,, Scollard D,, Jamieson F,, Broukhanski G,, Chedore P,, McCarthy A. 2012. Leprosy-like illness in a patient with Mycobacterium lepromatosis from Ontario, Canada. J Drugs Dermatol 11:229233.
79. Han XY,, Jessurun J. 2013. Severe leprosy reactions due to Mycobacterium lepromatosis. Am J Med Sci 345:6569.
80. Kendall BA,, Winthrop KL. 2013. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med 34:8794.
81. Kotilainen H,, Valtonen V,, Tukiainen P,, Poussa T,, Eskola J,, Järvinen A. 2013. Prognostic value of American Thoracic Society criteria for non-tuberculous mycobacterial disease: a retrospective analysis of 120 cases with four years of follow-up. Scand J Infect Dis 45:194202.
82. Wallace RJ,Jr,, Zhang Y,, Brown BA,, Dawson D,, Murphy DT,, Wilson R,, Griffith D.1998. Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med 158:12351244.
83. Fergie JE,, Milligan TW,, Henderson BM,, Stafford WW. 1997. Intrathoracic Mycobacterium avium complex infection in immunocompetent children: case report and review. J Infect Dis 24:250253.
84. Wolinsky E. 1995. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 20:954963.
85. Pierre-Audigier C,, Ferroni A,, Sermet-Gaudelus I,, Le Bourgeois M,, Offredo C,, Vu-Thien H,, Fauroux B,, Mariani P,, Munck A,, Bingen E,, Guillemot D,, Quesne G,, Vincent V,, Berche P,, Gaillard JL. 2005. Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 43:34673470.
86. Catherinot E,, Roux AL,, Vibet MA,, Bellis G,, Ravilly S,, Lemonnier L,, Le Roux E,, Bernède-Bauduin C,, Le Bourgeois M,, Herrmann JL,, Guillemot D,, Gaillard JL. 2013. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. J Cyst Fibros 12:7480.
87. Inderlied C,, Kempler C,, Bermudez L. 1993. The Mycobacterium avium complex. Clin Microbiol Rev 6:266310.
88. Turenne CY,, Wallace R,Jr,, Behr MA. 2007. Mycobacterium avium in the postgenomic era. Clin Microbiol Rev 20:205229.
89. Feller M,, Huwiler K,, Stephan R,, Altpeter E,, Shang H,, Furrer H,, Pfyffer GE,, Jemmi T,, Baumgartner A,, Egger M. 2007. Mycobacterium avium subspecies paratuberculosis and Crohn’s disease: a systematic review and meta-analysis. Lancet Infect Dis 7:607613.
90. Imirzalioglu C,, Dahmen H,, Hain T,, Billion A,, Kuenne C,, Chakraborty T,, Domann E. 2011. Highly specific and quick detection of Mycobacterium avium subsp. paratuberculosis in feces and gut tissue of cattle and humans by multiple real-time PCR assays. J Clin Microbiol 49:18431852.
91. Bruijnesteijn van Coppenraet LES,, de Haas PEW,, Lindeboom JA,, Kuijper EJ,, van Soolingen D. 2008. Lymphadenitis in children in caused by Mycobacterium avium hominissuis and not related to ‘bird tuberculosis.’ Eur J Clin Microbiol Infect Dis 27:293299.
92. Kaevska M,, Slana I,, Kralik P,, Reischl U,, Orosova J,, Holcikova A,, Pavlik I. 2011. Mycobacterium avium subsp. hominissuis” in neck lymph nodes of children and their environment examined by culture and triplex quantitative real-time PCR. J Clin Microbiol 49:167172.
93. Tortoli E,, Rindi L,, Garcia MJ,, Chiaradonna P,, Dei R,, Garzelli C,, Kroppenstedt RM,, Lari N,, Mattei R,, Mariottini A,, Mazzarelli G,, Murcia MI,, Nanetti A,, Piccoli P,, Scarparo C. 2004. Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. Int J Syst Evol Microbiol 54:12771285.
94. Schweickert B,, Goldenberg O,, Richter E,, Göbel UB,, Petrich A,, Buchholz P,, Moter A. 2008. Occurrence and clinical relevance of Mycobacterium chimaera sp. nov., Germany. Emerg Infect Dis 14:14431446.
95. Murcia MI,, Tortoli E,, Menendez MC,, Palenque E,, Garcia MJ. 2006. Mycobacterium colombiense sp. nov., a novel member of the Mycobacterium avium complex and description of MAC-X as a new ITS genetic variant. Int J Syst Evol Microbiol 56:20492054.
96. Vuorenmaa K,, Ben Salah I,, Barlogis V,, Chambost H,, Drancourt M. 2009. Mycobacterium colombiense and pseudotuberculous lymphadenopathy. Emerg Infect Dis 15:619629.
97. van Ingen J,, Boeree MJ,, Kösters K,, Wieland A,, Tortoli E,, Dekhuijzen RP,, van Soolingen D. 2009. Proposal to elevate Mycobacterium avium complex ITS sequevar MAC-Q to Mycobacterium vulneris sp. nov. Int J Syst Evol Microbiol 59:22772282.
98. Ben Salah I,, Cayrou C,, Raoult D,, Drancourt M. 2009. Mycobacterium marseillense sp. nov., Mycobacterium timonense sp. nov. and Mycobacterium bouchedurhonense sp. nov., novel species in the Mycobacteriun avium complex. Int J Syst Evol Microbiol 59:28032808.
99. Bang D,, Herlin T,, Stegger M,, Andersen AB,, Torkko P,, Tortoli E,, Thomsen VO. 2008. Mycobacterium arosiense sp. nov., a slowly growing, scotochromogenic species causing osteomyelitis in an immunocompromised child. Int J Syst Evol Microbiol 58:23982402.
100. Leguizamon J,, Hernandez J,, Murcia M-I,, Soto C-Y. 2013. Identification of potential biomarkers to distinguish Mycobacterium colombiense from other mycobacterial species. Mol Cell Probes 27:4652.
101. Tortoli E,, Tullia Simonetti M,, Dionisio D,, Meli M. 1994. Cultural studies on two isolates of Mycobacterium genavense from patients with acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis 18:712.
102. Tortoli E,, Brunello F,, Cagni AE,, Colombrita D,, Dionisio D,, Grisendi L,, Manfrin V,, Moroni M,, Passerini Tosi C,, Pinsi G,, Scarparo C,, Tullia Simonetti M. 1998. Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature. Eur J Epidemiol 14:219224.
103. Thomsen VO,, Dragsted UB,, Bauer J,, Fuursted K,, Lundgren J. 1999. Disseminated infection with Mycobacterium genavense: a challenge to physicians and microbiologists. J Clin Microbiol 37:39013905.
104. Hoop RK,, Böttger EC,, Pfyffer GE. 1996. Etiological agents of mycobacterioses in pet birds between 1986 and 1995. J Clin Microbiol 34:991992.
105. Saubolle MA,, Kiehn TE,, White MH,, Rudinsky MF,, Armstrong D. 1996. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of diseases in humans. Clin Microbiol Rev 9:435447.
106. Corbett EL,, Hay M,, Churchyard GJ,, Clayton T,, Williams BG,, Hayes D,, Mulder D,, de Cock KM. 1999. Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. Int J Tuberc Lung Dis 3:501507.
107. Cho JH,, Yu CH,, Jin MK,, Kwon O,, Hong KD,, Choi JY,, Yoon SH,, Park SH,, Kim CD,, Kim YL. 2012. Mycobacterium kansasii pericarditis in a kidney transplant recipient: a case report and comprehensive review of the literature. Transpl Infect Dis 14:E50E55. 10.1111/j.1399-3062.2012.00767.x.
108. Connick E,, Levi ME. 2011. Mycobacterium kansasii cutaneous abscesses occurring as immune reconstitution inflammatory syndrome. Int J Tuberc Lung Dis 15:993994.
109. Taillard C,, Greub G,, Weber R,, Pfyffer GE,, Bodmer T,, Zimmerli S,, Frei R,, Bassetti S,, Rohner P,, Piffaretti JC,, Bernasconi E,, Bille J,, Telenti A,, Prod’hom G. 2003. Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss national survey. J Clin Microbiol 41:12401244.
110. Talbot CL,, Rhodes B. 2012. An atypical mycobacterial infection of the shoulder. Int J Shoulder Surg 6:6466.
111. Brereton AS,, El Teraifi H. 2012. Mycobacterium malmoense: dissemination causes a popliteal aneurysm in a 74-year-old man. BMJ Case Rep. 2012:pii bcr/220115471. 10.1136/bcr12.2011.5471.
112. Broutin V,, Banuls A-L,, Aubry A,, Keck N,, Choisy M,, Bernardet J-F,, Michel C,, Raymond J-C,, Libert C,, Barnaud A,, Stragier P,, Portaels F,, Terru D,, Belon C,, Dereure O,, Gutierrez C,, Boschiroli M-L,, van de Perre P,, Cambau E,, Godreuil S. 2012. Genetic diversity and population structure of Mycobacterium marinum: new insights into host and environmental specificities. J Clin Microbiol 50:36273634.
113. Stinear TP,, Seemann T,, Harrison PF,, Jenkin GA,, Davies JK,, Johnson PD,, Abdellah Z,, Arrowsmith C,, Chillingworth T,, Churcher C,, Clarke K,, Cronin A,, Davis P,, Goodhead I,, Holroyd N,, Jagels K,, Lord A,, Moule S,, Mungall K,, Norbertczak H,, Quail MA,, Rabbinowitsch E,, Walker D,, White B,, Whitehead S,, Small PM,, Brosch R,, Ramakrishnan L,, Fischbach MA,, Parkhill J,, Cole ST. 2008. Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res 18:729741.
114. Ucko M,, Colorni A. 2005. Mycobacterium marinum infections in fish and humans in Israel. J Clin Microbiol 43:892895.
115. Braun E,, Sprecher H,, Davidson S,, Kassis I. 2013. Epidemiology and clinical significance of non-tuberculous mycobacteria isolated from pulmonary specimens. Int J Tuberc Lung Dis 17:9699.
116. Levy I,, Grisaru-Soen G,, Lerner-Geva L,, Kerem E,, Blau H,, Bentur L,, Aviram M,, Rivlin J,, Picard E,, Lavy A,, Yahav Y,, Rahav G. 2008. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis 14:378384.
117. Kent PT,, Kubica GP. 1985. Public Health Mycobacteriology: A Guide for the Level III Laboratory. Centers for Disease Control, US Department of Health and Human Services, Atlanta, GA.
118. Portaels F,, Silva MT,, Meyers WM. 2009. Buruli ulcer. Clin Dermatol 27:291305.
119. World Health Organization. 2012. Buruli Ulcer Disease. WHO Fact Sheet No. 199. World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs199/en/.
120. Portaels F,, Chemlal K,, Elsen P,, Johnson PDR,, Hayman JA,, Hibble J,, Kirkwood R,, Meyers WM. 2001. Mycobacterium ulcerans in wild animals. Rev Sci Tech 20:252264.
121. Affolabi D,, Sanoussi N,, Vandelannoote,, Odoun M,, Faihun F,, Sopoh G,, Anagonou S,, Portaels F,, Eddyani M. 2012. Effects of decontamination, DNA extraction, and amplification procedures on the molecular diagnosis of Mycobacterium ulcerans disease (Buruli ulcer). J Clin Microbiol 50:11951198.
122. Demangel C,, Stinear TP,, Cole ST. 2009. Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans. Nat Rev Microbiol 7:5060.
123. Doig KD,, Holt KE,, Fyfe JAM,, Lavender CJ,, Eddyani M,, Portaels F,, Yeboah-Manu D,, Pluschke G,, Seemann T,, Stinear TP. 2012. On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer. BMC Genomics 13:258277.
124. Grech M,, Carter R,, Thomson R. 2010. Clinical significance of Mycobacterium asiaticum isolates in Queensland, Australia. J Clin Microbiol 48:162167.
125. Lalande V,, Barbut F,, Vernerot A,, Febvre M,, Nesa D,, Wadel S,, Vincent V,, Petit JC. 2001. Pseudo-outbreak of Mycobacterium gordonae associated with water from refrigerated fountains. J Hosp Infect 48:7679.
126. Pinho L,, Santos J,, Oliveira G,, Pestana M. 2009. Mycobacterium gordonae urinary infection in a renal transplant recipient. Transpl Infect Dis 11:253256.
127. Verma N,, Spencer D. 2012. Disseminated Mycobacterium gordonae infection in a child with cystic fibrosis. Pediatr Pulmonol 47:518519.
128. Eckburg PB,, Buadu EO,, Stark P,, Sarinas PSA,, Chitkara RK,, Kuschner WG. 2000. Clinical and chest radiographic findings among persons with sputum culture positive for Mycobacterium gordonae. Chest 117:96102.
129. Tortoli E,, Gitti Z,, Klenk HP,, Lauria S,, Mannino R,, Mentagani P,, Mariottini A,, Neonakis I. 2013. Survey of 150 strains belonging to the Mycobacterium terrae complex and description of Mycobacterium engbaekii sp. nov., Mycobacterium heraklionense sp. nov. and Mycobacterium longobardum sp. nov. Int J Syst Evol Microbiol 63:401411.
130. Clinical and Laboratory Standards Institute (CLSI). 2008. Laboratory Detection and Identification of Mycobacteria. Document M48-A. CLSI, Wayne, PA.
131. Jensen PA,, Lamber LA,, Iademarco MF,, Rizon R. 2005. Guidelines for preventing transmission of Mycobacterium tuberculosis in health care settings. Morbid Mortal Wkly Rep 54(RR-17):1139.
132. Garcia LS. 2010. Clinical Microbiology Procedures Handbook, 3rd ed. ASM Press, Washington, DC.
133. Wallace R. 1987. Nontuberculous mycobacteria and water: a love affair with increasing clinical importance. Infect Dis Clin North Am 1:677686.
134. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. 2005. Controlling tuberculosis in the United States. Am J Respir Crit Care Med 172:11691227.
135. Mase SR,, Ramsay A,, Ng V,, Henry M,, Hopewell PC,, Cunningham J,, Urbanczik R,, Perkins MD,, Aziz MA,, Pai M. 2007. Yield of serial sputum specimen examinations in the diagnosis of tuberculosis: a systematic review. Int J Tuberc Lung Dis 11:485495.
136. Mixides G,, Shende V,, Teeter LD,, Awe R,, Musser JM,, Graviss EA. 2005. Number of negative acid-fast smears needed to adequately assess infectivity of patients with pulmonary tuberculosis. Chest 128:108115.
137. Monkongdee P,, McCarthy KD,, Cain KP,, Tasaneepayan T,, Dung NH,, Lan NT,, Yen NT,, Teeratakulpisarn N,, Udomsantisuk N,, Heilig C,, Varma JK. 2009. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with HIV. Am J Respir Crit Care Med 180:903908.
138. Noeske J,, Dopico E,, Torrea G,, Wang H,, van Deun A. 2009. Two vs. three sputum samples for microscopic detection of tuberculosis in a high HIV prevalence population. Int J Tuberc Lung Dis 13:842847.
139. Hepple R,, Ford N,, McNerney R. 2012. Microscopy compared to culture for the diagnosis of tuberculosis in induced sputum samples: a systematic review. Int J Tuberc Lung Dis 16:579588.
140. Archibald LK,, McDonald LC,, Addison RM,, McKnight C,, Byrne T,, Dobbie H,, Nwanyanwu O,, Kezembe P,, Reller LB,, Jarvis WR. 2000. Comparison of Bactec MYCO/F LYTIC and WAMPOLE ISOLATOR 10 (lysis-centrifugation) systems for detection of bacteremia, mycobacteremia, and fungemia in a developing country. J Clin Microbiol 3:29942997.
141. Kirby JE,, Delaney M,, Qian Q,, Gold HS. 2009. Optimal use of Myco/F Lytic and standard BACTEC blood culture bottles for detection of yeast and mycobacteria. Arch Pathol Lab Med 133:9396.
142. Hänscheid T,, Monteiro C,, Melo Cristino J,, Marques Lito L,, Salgano MJ. 2005. Growth of Mycobacterium tuberculosis in conventional BacT/Alert FA blood culture bottles allows reliable diagnosis of mycobacteremia. J Clin Microbiol. 43:890891.
143. Morris A,, Reller LB,, Salfinger M,, Jackson K,, Sievers A,, Dwyer B. 1993. Mycobacteria in stool specimens: the nonvalue of smears for predicting culture results. J Clin Microbiol 31:13851387.
144. Pfyffer GE,, Welscher HM,, Kissling P. 1997. Pretreatment of clinical specimens with sodium dodecyl (lauryl) sulfate is not suitable for the Mycobacteria Growth Indicator Tube cultivation method. J Clin Microbiol 35:21422144.
145. Padilla E,, Manterola JM,, Gonzalez V,, Thornton CG,, Quesada MD,, Sanchez MD,, Perez M,, Ausina V. 2005. Comparison of the sodium hydroxide specimen processing method with the C18-carboxypropylbetaine specimen processing method using independent specimens with auramine smear, the MB/BacT liquid culture system, and the COBAS AMPLICOR MTB test. J Clin Microbiol 43:60916097.
146. Ferroni A,, Vu-Thien H,, Lanotte P,, Le Bourgeois M,, Sermet-Gaudelus I,, Fauroux B,, Marchand S,, Varaigne F,, Berche P,, Gaillard J-L,, Offredo C. 2006. Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis. J Clin Microbiol 44:22372239.
147. Bobadilla-del-Valle M,, Ponce-de-Leon A,, Kato-Maeda M,, Hernandez-Cruz A,, Calva-Mercado JJ,, Chavez-Mazari B,, Caballero-Rivera BA,, Nolasco-Garcia JC,, Sifuentes-Osornio C. 2003. Comparison of sodium bicarbonate, cetyl-pyridinium chloride, and sodium borate for preservation of sputa for culture of Mycobacterium tuberculosis. J Clin Microbiol 41:44874488.
148. Cattamanchi A,, Davis JL,, Worodria W,, Yoo S,, Matovu J,, Kiidha J,, Nankya F,, Kyeyune R,, Andama A,, Joloba M,, Osmond D,, Hopewell P,, Huang L. 2008. Poor performance of universal sample processing method for diagnosis of pulmonary tuberculosis by smear microscopy and culture in Uganda. J Clin Microbiol 46:33253329.
149. Palomino JC,, Portaels F. 1998. Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the Bactec system. J Clin Microbiol 36:402408.
150. Yeboah-Manu D,, Bodmer T,, Mensah-Quainoo E,, Owusu S,, Ofori-Adjei D,, Pluschke G. 2004. Evaluation of decontamination methods and growth media for primary isolation of Mycobacterium ulcerans from surgical specimens. J Clin Microbiol 42:58755876.
151. Burman WJ,, Reves RR. 2000. Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment. Clin Infect Dis 31:13901395.
152. Yajko DM,, Nassos PS,, Sanders CA,, Gonzalez PC,, Reingold AL,, Horsburgh CR,, Hopewell P,, Chin DP,, Hadley WK. 1993. Comparison of four decontamination methods for recovery of Mycobacterium avium complex from stools. J Clin Microbiol 31:302306.
153. Lipsky BA,, Gates J,, Tenover FC,, Plorde JJ. 1984. Factors affecting the clinical value of microscopy for acid-fast bacilli. Rev Infect Dis 6:214222.
154. Yajko DM,, Nassos PS,, Sanders CA,, Madej JJ,, Hadley WK. 1994. High predictive value of the acid-fast smear for Mycobacterium tuberculosis despite the high prevalence of Mycobacterium avium complex in respiratory specimens. Clin Infect Dis 19:334336.
155. Wilmer A,, Bryce E,, Grant J. 2011. The role of the third acid-fast bacillus smear in tuberculosis screening for infection control purposes: a controversial topic revisited. Can J Infect Dis Med Microbiol 22(1):e1e3.
156. Trifiro S,, Bourgault A-M,, Lebel F,, René P. 1990. Ghost mycobacteria on Gram stain. J Clin Microbiol 28:146147.
157. Chen P,, Shi M,, Feng G-D,, Liu J-Y,, Wang B-J,, Shi X-D,, Ma L,, Liu X-D,, Yang Y-N,, Dai W,, Liu T-T,, He Y,, Li J-G,, Hao X-K,, Zhao G. 2012. A highly efficient Ziehl-Neelsen stain: identifiying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid. J Clin Microbiol 50:11661170.
158. Morris AJ,, Reller LB. 1993. Reliability of cord formation in BACTEC media for presumptive identification of mycobacteria. J Clin Microbiol 31:25332534.
159. Sanchez-Chardi A,, Olivares F,, Byrd TF,, Julian E,, Brambilla C,, Luquin M. 2011. Demonstration of cord formation by rough Mycobacterium abscessus variants: implications for the clinical microbiology laboratory. J Clin Microbiol 49:22932295.
160. Attorri S,, Dunbar S,, Clarridge JE,III. 2000. Assessment of morphology for rapid presumptive identification of Mycobacterium tuberculosis and Mycobacterium kansasii. J Clin Microbiol 38:14261429.
161. Joseph S,, Vaichulis E,, Houk V. 1967. Lack of auramine-rhodamine fluorescence of Runyon group IV mycobacteria. Am Rev Respir Dis 95:114115.
162. Somoskövi A,, Hotaling JE,, Fitzgerald M,, O’Donnell D,, Parsons LM,, Salfinger M. 2001. Lessons from a proficiency testing event for acid-fast microscopy. Chest 120:250257.
163. Minion J,, Pai M,, Ramsay A,, Menzies D,, Greenaway C. 2011. Comparison of LED and conventional fluorescence microscopy for detection of acid fast bacilli in a low-incidence setting. PLoS ONE 6:e22495. 10.1371/journal.pone.0022495.
164. Habtamu M,, van den Boogaard J,, Ndaro A,, Buretta R,, Irongo CF,, Lega DA,, Nyombi BM,, Kibiki GS. 2012. Light-emitting diode with various sputum smear preparation techniques to diagnose tuberculosis. Int J Tuberc Lung Dis 16:402407.
165. Cuevas LE,, Al-Sonboli A,, Lawson L,, Yassin MA,, Arbide I,, Al-Aghbari N,, Sherchand JB,, Al-Absi A,, Emenyonu EN,, Merid Y,, Okobi MI,, Onuoha JO,, Aschalew M,, Aseffa A,, Harper G,, Anderson de Cuevas RM,, Theobald SJ,, Nathanson C-M,, Joly J,, Faragher B,, Squire SB,, Ramsay A. 2011. LED fluorescence microscopy for the diagnosis of pulmonary tuberculosis: a multi-country cross-sectional evaluation. PLoS Med 8:e1001057. 10.1371/journal.pmed.1001057.
166. Xia H,, Song Y-Y,, Zhao B,, Kam K-M,, O’Brien RJ,, Zhang Z-Y,, Sohn H,, Wang W,, Zhao Y-L. 2013. Multicentre evaluation of Ziehl-Neelsen and light-emitting diode fluorescence microscopy in China. Int J Tuberc Lung Dis 17:107112.
167. Minion J,, Shenai S,, Vadwai V,, Tipnis T,, Greenaway C,, Menzies D,, Ramsay A,, Rodrigues C,, Pai M. 2011. Fading of auramine-stained mycobacterial smears and implications for external quality assurance. J Clin Microbiol 49:20242026.
168. Murray SJ,, Barrett A,, Magee JG,, Freeman R. 2003. Optimisation of acid-fast smears for the direct detection of mycobacteria in clinical samples. J Clin Pathol 56:613615.
169. European Society of Mycobacteriology. 1991. Decontamination, microscopy and isolation, p 5764. In Yates MD,, Groothuis DG (ed), Diagnostic Public Health Mycobacteriology. Bureau of Hygiene and Tropical Disease, London, United Kingdom.
170. Warren JR,, Bhattacharya M,, de Almeida KN,, Trakas K,, Peterson LR. 2000. A minimum 5.0 ml of sputum improves the sensitivity of acid-fast smear for Mycobacterium tuberculosis. Am J Respir Crit Care Med 161:15591562.
171. Saceanu C,, Pfeiffer N,, McLean T. 1993. Evaluation of sputum smears concentrated by cytocentrifugution for detection of acid-fast bacilli. J Clin Microbiol 31:23712374.
172. Woods GL,, Pentony E,, Boxley MJ,, Gatson AM. 1995. Concentration of sputum by cytocentrifugation for preparation of smears for detection of acid-fast bacilli does not increase sensitivity of the fluorochrome stain. J Clin Microbiol 33:19151916.
173. Yeboah-Manu D,, Danso E,, Ampah K,, Asante-Poku A,, Nakobu Z,, Pluschke G. 2011. Isolation of Mycobacterium ulcerans from swab and fine-needle-aspiration specimens. J Clin Microbiol 49:19971999.
174. Welch D,, Guruswamy A,, Sides S,, Shaw C,, Gilchrist M. 1993. Timely culture of mycobacteria which utilizes a microcolony method. J Clin Microbiol 31:21782184.
175. Clinical and Laboratory Standards Institute (CLSI). 2009. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes. Document M24-A2. CLSI, Wayne, PA.
176. Leung E,, Minion J,, Benedetti A,, Pai M,, Menzies D. 2011. Microcolony culture techniques of tuberculosis diagnosis: a systematic review. Int J Tuberc Lung Dis 16:1623.
177. Realini L,, de Ridder K,, Hirschel B,, Portaels F. 1999. Blood and charcoal added to acidified agar media promote growth of Mycobacterium genavense. Diagn Microbiol Infect Dis 34:4550.
178. Saito H,, Toda K,, Matsumoto I,, Matsuo K,, Nakanaga K,, Ishii N. 2004. Bacteriological features of Mycobacterium haemophilum isolated from skin lesions in an immunodeficient patient. Kansenshogaku Zasshi 78:389397.
179. Piersimoni C,, Scarparo C,, Callegaro A,, Passerini Tosi C,, Nista D,, Bornigia S,, Scagnelli M,, Rigon A,, Ruggiero G,, Goglio A. 2001. Comparison of MB/BacT Alert 3D System with radiometric Bactec System and Löwenstein-Jensen medium for recovery and identification of mycobacteria from clinical specimen: a multicenter study. J Clin Microbiol 39:651657.
180. Pfyffer GE,, Welscher HM,, Kissling P,, Cieslak C,, Casal MJ,, Gutierrez J,, Rüsch-Gerdes S. 1997. Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli. J Clin Microbiol 35:364368.
181. Whyte T,, Hanahoe B,, Collins T,, Corbett-Feeney G,, Cormican M. 2000. Evaluation of the Bactec MGIT 960 and MB/BacT Systems for routine detection of Mycobacterium tuberculosis. J Clin Microbiol 38:31313132.
182. Gravet A,, Souillard N,, Habermacher J,, Moser A,, Lohmann C,, Schmitt F,, Delarbre JM. 2011. Culture and susceptibility testing of mycobacteria with VersaTREK. Pathol Biol (Paris) 59:3238.
183. Cruciani M,, Scarpaio C,, Malena M,, Bosco O,, Serpelloni G,, Mengoli C. 2004. Meta-analysis of Bactec MGIT 960 and Bactec 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol 42:23212325.
184. Parrish N,, Dionne K,, Sweeney A,, Hedgepeth A,, Carroll K. 2009. Differences in time to detection and recovery of Mycobacterium spp. between the MGIT 960 and the BacT/ALERT MB automated culture systems. Diagn Microbiol Infect Dis 63:342345.
185. Crump JA,, Morrissey AB,, Ramadhani HO,, Njau BN,, Maro VP,, Reller LB. 2011. Controlled comparison of BacT/Alert MB System, manual Myco/F Lytic procedure, and Isolator 10 System for diagnosis of Mycobacterium tuberculosis bacteremia. J Clin Microbiol 49:30543057.
186. Pena JA,, Ferraro MJ,, Hoffmann CG,, Branda JA. 2012. Growth detection failures by the non-radiometric Bactec MGIT 960 mycobacterial culture system. J Clin Microbiol 50:20922095.
187. Tyrrell FC,, Budnick GE,, Elliott T,, Gillim-Ross L,, Hildred MV,, Mahlmeister P,, Parrish N,, Pentella M,, Vanneste J,, Wang YF,, Starks AM. 2012. Probability of negative Mycobacterium tuberculosis complex cultures based on time to detection of positive cultures: a multicenter evaluation of commercial-broth-based culture systems. J Clin Microbiol 50:32753282.
188. Pfyffer GE,, Wittwer F. 2012. Incubation time of mycobacterial cultures: how long is long enough to issue a final negative report to the clinician? J Clin Microbiol 50:41884189.
189. Shu Z,, Weigel KM,, Soelberg SD,, Lakey A,, Cangelosi GA,, Lee K-H,, Chung J-H,, Gao D. 2012. Cryopreservation of Mycobacterium tuberculosis complex cells. J Clin Microbiol 50:35733580.
190. Nienhaus A,, Schablon A,, Costa JT,, Diel R. 2011. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv Res 11:247257.
191. Gandra S,, Scott WS,, Somaraju V,, Wang H,, Wilton S,, Feigenbaum M. 2010. Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers. Infect Control Hosp Epidemiol 31:12791285.
192. Detjen AK,, Loebenberg L,, Grewal HM,, Stanley K,, Gutschmidt A,, Kruger C,, Du Plessis N,, Kidd M,, Beyers N,, Walzl G,, Hesseling AC. 2009. Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol 16:11701175.
193. Centers for Disease Control and Prevention. 2010. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States 2010. Morbid Mortal Wkly Rep 59:126.
194. Zellweger J-P,, Zellweger A,, Ansermet S,, de Senarclens B,, Wrighton-Smith P. 2005. Contact tracing using a new T-cell based test: better correlation with tuberculosis exposure than the tuberculin test. Int J Tuberc Lung Dis 9:12421247.
195. Pai M,, Zwerling A,, Menzies D. 2008. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149:177184.
196. Higuchi K,, Sekiya Y,, Igari H,, Watanabe A,, Harada N. 2012. Comparison of specificities between two interferon-gamma release assays in Japan. Int J Tuberc Lung Dis 16:11901192.
197. Diel R,, Goletti D,, Ferrara G,, Bothamley G,, Cirillo D,, Kampmann B,, Lange C,, Losi M,, Markova R,, Migliori GB,, Nienhaus A,, Ruhwald M,, Wagner D,, Zellweger JP,, Huitric E,, Sandgren A,, Manissero D. 2011. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and metaanalysis. Eur Respir J 37:8899.
198. Sester M,, Sotgiu G,, Lange C,, Giehl C,, Girardi E,, Migliori GB,, Bossink A,, Dheda K,, Diel R,, Dominguez J,, Lipman M,, Nemeth J,, Ravn P,, Winkler S,, Huitric E,, Sandgren A,, Manissero D. 2011. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 37:100111.
199. Chen J,, Zhang R,, Wang J,, Liu L,, Zheng Y,, Shen Y,, Qi T,, Lu H. 2011. Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis. PLoS One 6(11):e26827. 10.1371/journal.pone.0026827.
200. Denkinger CM,, Pai M,, Patel M,, Menzies D. 2013. Gamma interferon release assay for monitoring of treatment response for active tuberculosis: an explosion in the spaghetti factory. J Clin Microbiol 51:607610.
201. Diel R,, Loddenkemper R,, Meywald-Walter K,, Gottschalk R,, Nienhaus A. 2009. Comparative performance of tuberculin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis. Chest 135:10101018.
202. Stephan C,, Wolf T,, Goetsch U,, Bellinger O,, Nisius G,, Oremek G,, Rakus Z,, Gottschalk R,, Stark S,, Brodt HR,, Staszewski S. 2009. Comparing QuantiFERON-tuberculosis Gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 22:24712479.
203. Scrivo R,, Sauzullo I,, Mengoni F,, Priori R,, Coppola M,, Iaiani G,, Di Franco M,, Vullo V,, Mastroianni CM,, Valesini G. 2013. Mycobacterial interferon-release variations during longterm treatment with tumor necrosis factor blockers: lack of correlation with clinical outcome. J Rheumatol 40:157165.
204. Tavast E,, Salo E,, Seppälä I,, Tuuminen T. 2009. IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland. BMC Res Notes 2:918.
205. Kampmann B,, Whittaker E,, Williams A,, Walters S,, Gordon A,, Martinez-Alier N,, Williams B,, Crook AM,, Hutton AM,, Anderson ST. 2009. Interferon-gamma release assays do not identify more children with active TB than TST. Eur Respir J 33:13741382.
206. Mandalakas AM,, Detjen AK,, Hesseling AC,, Benedetti A,, Menzies D. 2011. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 15:10181032.
207. Zellweger J-P. 2008. Latent tuberculosis: which test in which situation? Swiss Med Wkly 138:3137.
208. Menzies D,, Pai M,, Comstock G. 2007. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection. Areas of uncertainty and recommendations for research. Ann Intern Med 146:340354.
209. Chee CBE,, Gan SH,, Khinmar KW,, Barkham TM,, Koh CK,, Liang S,, Wang YT. 2008. Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol 46:19351940.
210. Pai M,, Joshi R,, Dogra S,, Zwerling AA,, Gajalakshmi D,, Goswami K,, Reddy MVR,, Kalantri S,, Hill PC,, Menzies D,, Hopewell PC. 2009. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 13:8492.
211. Pai M,, O’Brien R. 2007. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med 4:980983.
212. Shah M,, Kasambira TS,, Adrian PV,, Madhi SA,, Martinson NA,, Dorman SE. 2011. Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study. PLoS One 6:e26787. 10.1371/journal.pone.0026787.
213. van Zyl-Smit RN,, Pai M,, Peprah K,, Meldau R,, Kieck J,, Jurizu J,, Badri M,, Zumla A,, Sechi LA,, Bateman ED,, Dheda K. 2009. Within-subject variability and boosting of T-cell interferon-γ responses after tuberculin skin testing. Am J Respir Crit Care Med 180:4958.
214. Talati NJ,, Seybold U,, Humphrey B,, Aina A,, Tapia J,, Weinfurter P,, Albalak R,, Blumberg HM. 2009. Poor concordance between interferon-gamma release assays and tuberculin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis 9:1524.
215. Bergamini BM,, Losi M,, Valenti F,, D’Amico R,, Meccugni B,, Meacci M,, de Giovanni D,, Rumianesi F,, Fabbri LM,, Balli F,, Richeldi L. 2009. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics 123:e419e424.
216. Kobashi Y,, Sugiu T,, Shimizu H,, Ohue Y,, Mouri K,, Obase Y,, Miyashita N,, Oka M. 2009. Clinical evaluation of the T-SPOT.TB Test for patients with indeterminate results on the QuantiFERON TB-2G Test. Intern Med 48:137142.
217. Banach DB,, Harris TG. 2011. Indeterminate QuantiFERON-TB Gold results in a public health clinic setting. Int J Tuberc Lung Dis 15:16231629.
218. Herrera V,, Yeh E,, Murphy K,, Parsonnet J,, Banaei N. 2010. Immediate incubation reduces indeterminate results for QuantiFERON TB Gold In-Tube assay. J Clin Microbiol 48:26722676.
219. Doberne D,, Gaur RL,, Banaei N. 2011. Preanalytical delay reduces sensitivity of QuantiFERON-TB Gold In-Tube Assay for detection of latent tuberculosis infection. J Clin Microbiol 49:30613064.
220. Centers for Disease Control and Prevention. 1997. Multiple misdiagnoses of tuberculosis resulting from laboratory error—Wisconsin 1996. Morbid Mortal Wkly Rep 46:797801.
221. Killeen AA. 2009. Laboratory sanctions for proficiency testing sample referral and result communication: a review of actions from 1993–2006. Arch Pathol Lab Med 133:979982.
222. Hawkins JE,, Good RC,, Kubica GP,, Gangadharam PRJ,, Gruft HM,, Stottmeier KD,, Sommers HM,, Wayne LG. 1983. Levels of laboratory services for mycobacterial diseases: official statement of the American Thoracic Society. Am Rev Respir Dis 128:213.
223. Woods GL,, Ridderhof JC. 1996. Quality assurance in the mycobacteriology laboratory. Clin Lab Med 16:657675.
224. Clinical and Laboratory Standards Institute (CLSI). 2006. Molecular Diagnostic Methods for Infectious Diseases. Document MM03-A2. CLSI, Wayne, PA.
225. Centers for Disease Control and Prevention. 2013. Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use—United States, 2013. Morbid Mortal Wkly Rep 62:821824.
226. Masaki T,, Ohkusu K,, Hata H,, Fujiwara N,, Iihara H,, Yamada-Noda M,, Nhung PH,, Hayashi M,, Asano Y,, Kawamura Y,, Ezaki T. 2006. Mycobacterium kumamotonense sp. nov., recovered from clinical specimen and the first isolation report of Mycobacterium arupense in Japan: novel slowly growing, non-chromogenic clinical isolates related to Mycobacterum terrae complex. Microbiol Immunol 50:889897.
227. Tsai TF,, Lai CC,, Chang CH,, Hsiao CH,, Hsueh PR. 2006. Tenosynovitis caused by Mycobacterium arupense in a patient with diabetes mellitus. Clin Infect Dis 47:861863.
228. Huber J,, Richter E,, Binder L,, Maass M,, Eberl R,, Zenz W. 2008. Mycobacterium bohemicum and cervical lymphadenitis. Emerg Infect Dis 14:11581159.
229. Poulin S,, Corbeil C,, Nguyen M,, St-Denis A,, Coté L,, Le Deist F,, Carignan A. 2013. Fatal Mycobacterium colombiense/cytomegalovirus coinfection associated with acquired immunodeficiency due to autoantibodies against interferon gamma: a case report. BMC Infect Dis 13:2429.
230. van Ingen J,, Boeree MJ,, Stals FS,, Pitz CCM,, Rooijmans-Rietjens JJCM,, van der Zanden AGM,, Dekhuijzen PNR,, van Soolingen D. 2007. Clinical Mycobacterium conspicuum isolation from two immunocompetent patients in the Netherlands. J Clin Microbiol 45:40754076.
231. Tortoli E,, Piersimoni C,, Kroppenstedt RM,, Montoya-Burgos JI,, Reischl U,, Giacometti A,, Emler S. 2001. Mycobacterium doricum sp. nov. Int J Syst Evol Microbiol 51:20072012.
232. Pettit AC,, Jahangir AA,, Wright PW. 2011. Mycobacterium doricum osteomyelitis and soft tissue infection. Emerg Infec Dis 17:20752076.
233. Tortoli E,, Böttger E,, Fabio A,, Falsen E,, Gitti Z,, Grottola A,, Klenk HP,, Mannino R,, Mariottini A,, Messino M,, Pecorari M,, Rumpianesi F. 2011. Mycobacterium europaeum sp. nov., a scotochromogenic species related to the Mycobacterium simiae complex. Int J Syst Evol Microbiol 61:16061611.
234. Tortoli E,, Rindi L,, Goh KS,, Katila ML,, Mariottini A,, Mattei R,, Mazzarelli G,, Suomalainen S,, Torkko P,, Rastogi N. 2005. Mycobacterium florentinum sp. nov., isolated from humans. Int J Syst Evol Microbiol 55:11011106.
235. Ramos JP,, Campos CE,, Caldas PC,, Ferreira NV,, da Silva MV,, Redner P,, Campelo CL,, Vale SF,, Barroso EC,, Medeiros RF,, Montes FC,, Galvao TC,, Tortoli E. 2013. Mycobacterium fragae sp. nov., a non-chromogenic species isolated from human respiratory specimens. Int J Syst Evol Microbiol 63:25832587.
236. Okazaki M,, Ohkusu K,, Hata H,, Ohnisi H,, Sugahara K,, Kawamura C,, Fujiwara N,, Matsumoto S,, Nishiuchi Y,, Toyoda K,, Saito H,, Yonetani S,, Fukugawa Y,, Yamamoto M,, Wada H,, Sejimo A,, Ebina A,, Goto H,, Ezaki T,, Watanabe T. 2009. Mycobacterium kyorinense sp. nov., a novel slow-gowing species, related to Mycobacterium celatum, isolated from human clinical specimens. Int J Syst Evol Microbiol 59:13361341.
237. Dias Campos CE,, de Souza Caldas PC,, Ohnishi H,, Watanabe T,, Ohtsuka K,, Matsushima S,, Ferreira NV,, Villas Boas da Silva M,, Redner P,, Distasio de Carvalho L,, Ferreira de Melo Medeiros R,, Abbud Filho JA,, Onofre Fandinho Montes C,, Calcagno Galvao T,, Pais Ramos J. 2012. First isolation of Mycobacterium kyorinense from clinical specimens in Brazil. J Clin Microbiol 50:24772478.
238. Hong SK,, Sung JY,, Lee HJ,, Oh MD,, Park SS,, Kim EC. 2013. First case of Mycobacterium longobardum infection. Ann Lab Med 33:356359.
239. van Ingen J,, Lindenboom JA,, Hartwig NG,, de Zwaan RE,, Tortoli E,, Dekhuijzen RP,, Boeree MJ,, van Soolingen D. 2009. Mycobacterium mantenii sp. nov., a pathogenic, slowly growing, scotochromogenic mycobacterium. Int J Syst Evol Microbiol 59:27822787.
240. Mohamed AM,, Iwen PC,, Tarantolo S,, Hinrichs SH. 2004. Mycobacterium nebraskense sp. nov., a novel slowly growing scotochromogenic species. Int J Syst Evol Microbiol 54:20572060.
241. Turenne CY,, Cook VJ,, Burdz TV,, Pauls RJ,, Thibert L,, Wolfe JN,, Kabani A. 2004. Mycobacterium parascrofulaceum sp. nov., novel slowly growing, scotochromogenic clinical isolates related to Mycobacterium simiae. Int J Syst Evol Microbiol 54:15431551.
242. Lee HK,, Lee S-A,, Lee I-K,, Yu H-K,, Park Y-G,, Hyun J-W,, Kim K,, Kook Y-H,, Kim B-J. 2010. Mycobacterium paraseoulense sp. nov., a slowly growing, scotochromogenic species related genetically to Mycobacterium seoulense. Int J Syst Evol Microbiol 60:439443.
243. Fanti F,, Tortoli E,, Hall L,, Roberts GD,, Kroppenstedt RM,, Dodi I,, Conti S,, Polonelli L,, Chezzi C. 2004. Mycobacterium parmense sp. nov. Int J Syst Evol Microbiol 54:11231127.
244. van Ingen J,, Al-Hajoj SA,, Boeree M,, Al-Rabiah F,, Enaimi M,, de Zwaan R,, Tortoli E,, Dekhuijzen,, van Soolingen D. 2009. Mycobacterium riyadhense sp. nov., a non-tuberculous species identified as Mycobacterium tuberculosis complex by a commercial line-probe assay. Int J Syst Evol Microbiol 59:10491053.
245. Godreuil S,, Marchandin H,, Michon A-L,, Ponsada M,, Chyderiotis G,, Brisou P,, Bhat A,, Panteix G. 2012. Mycobacterium riyadhense pulmonary infection, France and Britain. Emerg Infect Dis 18:176178.
246. Turenne CY,, Thibert L,, Williams K,, Burdz TV,, Cook VJ,, Wolfe JN,, Cockcroft DW,, Kabani A. 2004. Mycobacterium saskatchewanense sp. nov., a novel slowly growing scotochromogenic species from human clinical isolates related to Mycobacterium interjectum and Accuprobe-positive for Mycobacterium avium complex. Int J Syst Evol Microbiol 54:659667.
247. van Ingen J,, Tortoli E,, Selvarangan R,, Coyle MB,, Crump JA,, Morrissey AB,, Dekhuijzen PNR,, Boeree MJ,, van Soolingen D. 2011. Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species. Int J Syst Evol Microbiol 61:12931298.
248. Selvarangan R,, Wu W-K,, Nguyen TT,, Carlson LDC,, Wallis CK,, Stiglich SK,, Chen Y-C,, Jost, KC,Jr,, Prentice JL,, Wallace, RJ,Jr,, Barrett SL,, Cookson BT,, Coyle MB. 2004. Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov. J Clin Microbiol 42:5259.
249. Tajan J,, Spasa M,, Sala M,, Navarro M,, Font B,, Gonzalez-Martin J,, Segura F. 2013. Disseminated infection by Mycobacterium sherrisii and Histoplasma capsulatum in an African HIV-infected patient. Am J Trop Med Hyg 88:914917.
250. Mun HS,, Park JH,, Kim H,, Yu HK,, Park YG,, Cha CY,, Kook YH,, Kim BJ. 2008. Mycobacterium senuense sp. nov., a slowly growing, nonchromogenic species closely related to the Mycobacterium terrae complex. Int J Syst Evol Microbiol 58:641646.
251. Mun HS,, Kim HJ,, Oh EJ,, Kim H,, Bai GH,, Yu HK,, Park YG,, Cha CY,, Kook YH,, Kim BJ. 2007. Mycobacterium seoulense sp. nov., a slowly growing scotochromogenic species. Int J Syst Evol Microbiol 57:594599.
252. Nakanaga K,, Hoshino Y,, Wakabayashi M,, Fujimoto N,, Tortoli E,, Makino M,, Tanaka T,, Ishii N. 2012. Mycobacterium shigaense sp. nov., a novel slowly growing scotochromogenic mycobacterium that produced nodules in an erythroderma patient with severe cellular immunodeficiency and a history of Hodgkin’s disease. J Dermatol 39:389396.
253. Palmore TN,, Shea YR,, Conville PS,, Witebsky FG,, Anderson VL,, Rupp Hodge IP,, Holland SM. 2009. Mycobacterium tilburgii,” a newly described, uncultivated opportunistic pathogen. J Clin Microbiol 47:15851587.
254. Hartwig NG,, Warris A,, van de Vosse E,, van der Zanden AGM,, Schülin-Casinato T,, van Ingen J,, van Hest R. 2011. Mycobacterium tilburgii” infection in two immunocompromized children: importance of molecular tools in culture-negative mycobacterial disease diagnosis. J Clin Microbiol 49:44094411.
255. Kim BJ,, Math RK,, Jeon CO,, Yu HK,, Park YG,, Kook YH,, Kim BJ. 2013. Mycobacterium yongonense sp. nov., a slow-growing non-chromogenic species closely related to Mycobacterium intracellulare. Int J Syst Evol Microbiol 63:192199.
256. Tortoli E,, Mariottini A,, Pierotti P,, Simonetti TM,, Rossolini GM. 2013. Mycobacterium yongonense in pulmonary disease, Italy. Emerg Infect Dis 19:19021904.
257. Federal Government. 2014. CFR, Title 42—Public Health. Chapter I—Public Health Service, Department of Health and Human Services. Subchapter F—Quarantine, Inspection, Licensing. Part 72—Interstate Transportation of Etiologic Agents. U.S. Federal Government, Washington, DC. http://www.gpo.gov/fdsys/granule/CFR-2007-title42-vol1/CFR-2007-title42-vol1-part72.
258. Federal Government. 2014. CFR, Title 49—Transportation. Chapter I—Pipeline and Hazardous Materials Safety Administration, Department of Transportation. Subchapter C—Hazardous Materials Regulations. Parts 171 to 180. U.S. Federal Government, Washington, DC. http://www.ecfr.gov/cgi-bin/text-idx?SID=c5250b44293a9c4f37cd4ec0e9f7afe1&tpl=/ecfrbrowse/Title49/49CIsubchapC.tpl.
259. Federal Government. 2014. CFR, Title 39—Postal Service. Chapter I—United States Postal Service. Subchapter B— International Mail. Part 20—International Postal Service. U.S. Federal Government, Washington, DC. http://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&tpl=/ecfrbrowse/Title39/39cfr20_main_02.tpl.
260. Federal Government. 2014. CFR, Title 39, Part 111. General Information on Postal Service. U.S. Federal Government, Washington, DC. http://www.ecfr.gov/cgi-bin/text -idx?rgn=div5&node=39:1.0.1.3.12.
261. U.S. Postal Service. 2014. 346. Toxic substances and infectious substances (hazard class 6), in Publication 52 - Hazardous, Restricted, and Perishable Mail. U.S. Postal Service, Washington, DC. http://pe.usps.com/text/pub52/ pub52c3_023.htm.
262. U.S. Postal Service. 2014. International Mail Manual, Section 135, Dangerous Mailable Goods. U.S. Postal Service, Washington, DC. http://pe.usps.com/text/imm/im mc1_014.htm.
263. Occupational Safety and Health Administration (OSHA). 2014. 29 CFR, Part 1910. Occupational Safety and Health Standards. Subpart Z, Toxic and Hazardous Substances. Standard 1030, Bloodborne Pathogens. Department of Labor, U.S. Federal Government, Washington, DC. https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS.